Tirzepatide 30mg reconstitution calculator: why this search is a safety concern

What official guidance actually says about tirzepatide dosing in the UK

The MHRA-licensed version of tirzepatide in the UK is Mounjaro, manufactured by Eli Lilly and supplied as a pre-filled KwikPen. Each pen delivers four weekly doses at a fixed concentration; the patient turns a dial and injects. There is no mixing step, no bacteriostatic water, no insulin syringe, and no calculator required. The licensed UK dose range runs from 2.5mg (a tolerability starting point, not a treatment target) up to 15mg as the maximum maintenance dose, titrated by a prescriber roughly every four weeks. This schedule is set out in the Mounjaro Summary of Product Characteristics on the electronic Medicines Compendium, which remains the authoritative UK reference for dosing and storage, and which contains no 30mg figure of any kind.

NICE's appraisal of tirzepatide (TA1026, published December 2024) assessed the medicine at the doses studied in the SURMOUNT programme: 5mg, 10mg and 15mg as maintenance doses, with 2.5mg as the starting ramp. A 30mg dose was not evaluated, not recommended, and does not appear in any NHS or MHRA-sanctioned clinical pathway. Framing a tirzepatide 30mg reconstitution calculator as a clinical tool misrepresents what UK guidance actually endorses.

For anyone curious about the general mechanics of a tirzepatide reconstitution calculator, that page covers the context more broadly, but the underlying conclusion is the same: if the pen you have received requires reconstitution, it did not come from the licensed UK supply chain.

The source problem: where 30mg reconstitution figures come from

Raw or lyophilised tirzepatide peptide is sold online, often described as being "for research use only". Buyers dissolve it in bacteriostatic water to create an injectable solution, and they use online calculators to work out how much water to add to hit a target concentration. A 30mg vial is a common format in this grey market, hence the search term. This is not a fringe phenomenon. The MHRA seized roughly 20 million doses of illegally traded weight-loss medicines (worth around £45 million) and in October 2025 raided the first illicit UK manufacturing site producing counterfeit tirzepatide pens, in Northampton. The MHRA's Yellow Card reporting tool allows anyone who encounters suspect products to report them, and the regulator has been clear: these preparations have not been assessed for sterility, potency, or the presence of contaminants.

A homemade tirzepatide solution carries risks that a licensed KwikPen does not. Incorrect reconstitution leads to overdose or under-dose. Contamination risks are real when sterile technique is not maintained in a pharmaceutical environment. And because raw peptide purity is not regulated at the point of retail, what is sold as 30mg tirzepatide may contain something else entirely, a pattern that has led to hospitalisations in counterfeit semaglutide cases. Our page on 30mg tirzepatide reconstitution explains why this specific format sits entirely outside the licensed UK supply chain and what the practical risks of using it are. The search for a tirzepatide 30mg reconstitution calculator online is, in almost every case, the start of a process the MHRA has explicitly warned against.

If you are currently on compounded or grey-market tirzepatide and want to move to licensed treatment, our FAQs cover how transfer consultations work at nume.

What the licensed product looks like in practice

A Mounjaro KwikPen dispensed through a GPhC-registered pharmacy arrives in plain, unbranded packaging via DPD next-working-day tracked delivery. Inside, the pen is pre-filled and colour-coded to its strength. There is a patient information leaflet; the dose is set at the factory. Injection requires attaching a needle, dialling the dose indicator (not a volume, a strength, the device handles the rest), and pressing the button at the injection site. That is the full process. No reconstitution, no syringe drawing, no calculator.

Storage is refrigerated at 2–8°C; the exact out-of-fridge window before a pen must be discarded is specified in the patient information leaflet and should be followed precisely. The NHS tirzepatide medicines page gives a practical patient-level overview of how Mounjaro is used, stored and what side effects to watch for. For deeper clinical detail (storage windows, contraindications, special populations) the Mounjaro SmPC on the eMC is the primary reference.

Understanding how Mounjaro works as a dual GIP and GLP-1 receptor agonist, and what the SURMOUNT trial results showed, gives useful context if you are weighing up licensed treatment. The evidence base was built on a pre-filled, factory-standardised medicine, not on home-mixed preparations, and not at 30mg.

The path to licensed tirzepatide if you do not yet have a prescription

A prescription for Mounjaro in the UK requires a clinical assessment by a registered prescriber. That assessment looks at your BMI, any weight-related conditions, your medication history, and whether tirzepatide is appropriate for you specifically. The prescriber sets the starting dose and the titration plan; the pharmacy fills the prescription with a pre-filled pen at that exact dose. You do not need to calculate anything.

Eligibility under the licensed indication covers adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, dyslipidaemia, or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone is not sufficient for approval; the prescriber reviews the full picture. Details of the private route through a regulated pharmacy are on our treatment consultation page, and a broader look at what the evidence says about weight-loss treatments is on our weight loss overview.

If cost is part of what drove the search for a compounded product, the Mounjaro private prescription guide explains what a legitimate price includes (prescription, clinical review, dispensing, and tracked delivery) and why price alone is the wrong filter for a prescription medicine. A question our prescribers hear regularly: "Is the cheaper option online the same thing?" The honest answer is that it depends entirely on whether that cheaper option came through a regulated UK supply chain, and anyone reconstituting tirzepatide 30mg at home is working with a product that did not. We also explain what distinguishes grey-market preparations from the licensed pen on our page covering tirzepatide 60mg reconstitution, another format that exists only outside the MHRA-approved supply chain.